Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice
J. Clin. Invest. Andrew C. Li, et al. 106:523 doi:10.1172/JCI10370 [
Go to this article.]
Figure 2Size distribution of lipoprotein particles in LDLR
–/– mice fed a high-fat, cholesterol-enriched diet and treated with solvent (control; diamonds), rosiglitazone (squares), or GW7845 (triangles) for 10 weeks. Plasma was pooled from four mice from each treatment group and fractionated by FPLC. Mean cholesterol content in each fraction was determined in duplicate.
